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ABSTRACT
Objective: To compare the pain control results of ketoprofen suppository and periprostatic injection of lidocaine 1% for 
prostate biopsy. Material & Method: A total of 30 patients who underwent transrectal ultrasound guided prostate biopsy 
were randomized into 2 groups. Group 1 consisted of 15 patients received 200 mg of ketoprofen suppository. Group 2 
received 1% periprostatic lidocaine injection. A visual analog scale was used to assess the pain score during prostate 
biopsy. Statistical analysis of pain scores was performed using independent t-test and Pearson correlation test. Results: 
The 2 groups were homogenous in age and prostate volume. There was significant difference in pain score among groups 1 
and 2 during prostate biopsy (mean VAS ± SD 0,8 ± 0,8 and 4,5 ± 1,6 respectively, p < 0,0001). There was no significant 
correlation between pain perception with age (p = 0,779), or prostate volume (p = 0,389) in both groups. Conclusion: 
Periprostatic lidocaine injection is more effective for decreasing the pain for prostate biopsy compared to ketoprofen 
suppository.
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ABSTRAK
Tujuan Penelitian: Membandingkan persepsi nyeri antara pemberian ketoprofen supositoria dengan injeksi lidokain 1% 
periprostatika pada TRUS guided prostate biopsy. Bahan & Cara: Penelitian ini bersifat prospektif, randomized clinical 
trial, pada 30 pasien biopsi prostat. Tiga pasien dieksklusi karena hasil pemeriksaan patologi anatomi adenokarsinoma 
prostat. Pasien dirandomisasi, 13 pasien diberikan ketoprofen 200 mg suppositoria (kelompok 1) dan 14 pasien diinjeksi 
lidokain 1% periprostatika (kelompok 2) sebelum biopsi prostat. Pasien ditanya skala nyeri saat biopsi menggunakan 
visual analog scale (VAS), kemudian dianalisa statistik dengan t-independent test dan uji korelasi Pearson. Hasil 
Penelitian: Umur dan volume prostat pasien homogen pada kedua kelompok. Injeksi lidokain 1% periprostatika 
mengurangi nyeri secara signifikan dibandingkan dengan ketoprofen supositoria dengan skala VAS ± SD 0,8 ± 0,8 vs 4,5 ± 
1,6 dengan p < 0,0001. Tidak ada hubungan yang signifikan antara persepsi nyeri dengan umur (p = 0,779), dan volume 
prostat (p = 0,389) pada kedua kelompok. Simpulan: Nyeri biopsi prostat berkurang secara signifikan pada injeksi 
lidokain 1% periprostatika dibandingkan ketoprofen supositoria, juga tidak didapatkan hubungan antara persepsi nyeri 
dengan umur dan volume prostat pada biopsi prostat.
Kata Kunci: Biopsi prostat, nyeri, transrectal ultrasonography, periprostatic nerve block, visual analog scale.
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INTRODUCTION
Prostate cancer is the fourth most common 
1malignancy in men,  approximately 15% of cancers 
in men in developed countries and 4% in developing 
2countries.  Prostate cancer deaths in the United 
States are approximately 30,000 cases/year, 
decreasing 25% over the previous decade. It was 
suggested to have correlation with prostate cancer 
early detection program. The program initially 
involves examination of prostate specific antigen 
3,4(PSA) and digital rectal examination.  In 1989, 
Hodge introduced the systematic sextant prostate 
biopsy procedures under guidance of transrectal 
ultrasonography (TRUS), which later became the 
procedure of choice and gold standard for the 
84
3,4,5diagnosis of prostate cancer.
TRUS guided prostate biopsy procedure is 
safe and can be performed on an outpatient basis. In 
the United States about 500,000 TRUS guided 
prostate biopsies are performed each year. However, 
3,6this procedure causes discomfort and pain.  
Approximately 65-90% of patients felt pain during 
the action, and nearly 20% experience significant 
pain and refused re-biopsy was performed without 
3,7,8analgesic/aenesthesia.  Six percent patients regard 
this procedure very painful and must be performed 
8,9under general anesthesia.
Nash (1996) pioneered the use of 1% 
lidocaine injection into the prostate nerve bundles to 
5reduce pain during prostate biopsy,  and found a 
significant decrease in pain compared to patients 
10without lidocaine injection.  Another method using 
diclofenac suppositories, which has local and 
general analgesic effect with low complications. 
There are significant differences in the patients who 
were given with diclofenac suppository on prostate 
biopsy, where only 4 patients with a score of visual 
analog scale (VAS) > 5 and 11 patients received 
11placebo.
Periprostatic nerve block (PNB) with 1% 
lidocaine injection anesthesia is the technique most 
frequently performed and is considered as the gold 
8,12standard.  A study of 90 patients found an average 
pain score of 1,51 on the injection of lidocaine 1% 
7compared to 3,98 in the control group.  Another 
study comparing the provision of intrarectal 
lidocaine jelly found differences in the average pain 
3score in lidocaine injection 2,4 vs  3,7.  About 93% 
had only mild pain on periprostatic injection of 1% 
lidocaine. Whereas, in patients without anesthesia, 
55% felt the pain significantly, even 10% required 
13sedation.  Other researchers revealed average pain 
14score of 2,6 in periprostatic lidocaine injection.  
Approximately 84% of patients with injection of 
lidocaine 1% had VAS scores < 5,9 of 50 patients, 
15only 1 patient felt pain in this procedure.
In Dr. Soetomo Hospital Surabaya, to reduce 
pain during TRUS guided prostate biopsy, we used 
ketoprofen suppositories 200 mg/rectal.
OBJECTIVE
To determine differences in pain perception 
between ketoprofen suppositories with periprostatic 
1% lidocaine injection in TRUS guided prostate 
biopsy using VAS scores.
       
MATERIAL & METHOD
This study was a prospective randomized 
clinical trial. Study sample were BPH LUTS patients 
in Dr. Soetomo Hospital Surabaya with TRUS 
guided prostate biopsy indication. Inclusion criteria 
were suspicion prostate malignancy with PSA > 4 
ng/ml, PSAD > 0,15; digital rectal examination 
revealed hard, nodular, or asymmetrical prostate; 
lesions found on TRUS prostate were hypo- or 
hyperechoic. The exclusion criteria were patients 
who had previous prostate biopsy, prostate cancer, 
prostatitis, rectal infections, hemorrhoids, anal 
fissure, blindness or cataracts; currently using 
analgesics or anticoagulant/antiplatelet, allergy to 
lidocaine and ketoprofen.
The research was conducted in January to 
March 2011 with a sample size of 30 patients, each 
15 patients per group. Two patients of group 1 and 
group 2 were excluded because of the anatomic 
pathology of prostate adenocarcinoma. The night 
before the biopsy, the patients were given enemas. 
Before the procedure, prophylactic antibiotics were 
provided. Randomization was done for the 
Figure 1. Transrectal ultrasound of prostate and seminal vesicles. A) Arrows indicate the injection of lidocaine, B) After 
injection of the seminal vesicles are lifted and separated from the perirectal fat.3
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allocation of groups 1 and 2. The position of the 
patient was left lateral decubitus. Group 1 was given 
with 200 mg ketoprofen suppositories per rectal, one 
hour later prostate biopsies were performed. Group 2 
was given local injection of periprostatic 1% 
lidocaine at the lateral area of the junction of the 
seminal vesicles and prostate base using a 22G spinal 
needle and a length of 7 inches by 7 MHz TRUS 
guidance with sagittal cuts (Fig. 1). The injection is 
appropriate if seminal vesicles are lifted and 
separated from rectal wall or perirectal fat. Five 
minutes later we performed a prostate biopsy with 
10-core technique using 18G biopsy needle. After 
the biopsy, the patients determined the degree of pain 
that is felt on the score. Interpretation of the pain was 
as follows: score 0 no pain, 1-3 mild pain, 4-7 
moderate pain, and 8-10 severe pain.
Data distribution normality test was 
performed with Kolmogorov-Smirnov test. Data 





 p Ketoprofen 
                    
n = 13 (%)
Lidocaine 
                    
n = 14 (%)
Age (year) 
     Range 
     Mean ± SD 
Volume prostate (cc)      Range 
     Mean ± SD 
 
50 – 80 
63,5 ± 8,5  
22,1 – 86,4 
37,6 ± 17,7 
 
51 – 78 
66,1 ± 7,0  
21,5 – 127,4 




Figure 2. VAS differences between groups.
Table 1. Characteristics of the study sample.
the degree of significance of p < 0,05. For correlation 
test we used Pearson test.
Age (years) 
VAS (%)  
Total 
No pain Mild pain Moderate pain
≤ 60 1 (20,0) 2 (40,0) 2 (40,0) 5 (100,0) 
61 – 70 4 (22,2) 9 (50,0) 5 (27,8) 18 (100,0) 
> 70 0 (0,0) 2 (50,0) 2 (50,0) 4 (100,0) 
Total 5 (18,5) 13 (48,1) 9 (33,3) 27 (100,0) 
Table 2. Correlation between VAS values and age.
RESULTS
Based on the test for normality of data 
distribution by Kolmogorov-Smirnov test, obtained 
the distribution of age (p = 0,378) and prostate 
volume (0,244) of patients were normal or 
homogeneous in both study groups (Table 1).
Evaluation of patient perception of pain 
during a prostate biopsy is shown in Figure 2. In 
group 1, the VAS value was 4,5 ± 1,6. While in the 
second group, the VAS was 0,8 ± 0,8. In group 1, as 
many as 9 patients (69,2%) felt moderate pain and 4 
patients (30,8%) mild pain. Whereas in group 2, a 
total of 5 patients (35,7%) had no pain and 9 patients 
(64,3%) only mild pain. Statistical tests with 
independent t-test revealed p < 0,0001, indicating 
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VAS 4.5 + 1.6
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VAS 0.8 + 0.8
p = 0.0001
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VAS values, where the periprostatic injection of 
lidocaine 1% was better in pain control than 
ketoprofen suppository on prostate biopsy.
Pearson correlation test was performed to 
assess the relationship between the perception of 
pain (VAS) with patients' age, revealing p = 0,779. 
This shows no significant correlation between the 
age of the patient's and their perception of pain in 
prostate biopsy in both study groups (Table 2). 
Similarly, no significant correlation was found 
between the perception of pain with the prostate 
volume of the patients in both study groups, p = 
0,389 (Table 3).
DISCUSSION
Prostate biopsy is a safe procedure, but 
patients experience significant pain in this 
procedure. Pain during TRUS of the prostate biopsy 
is a remarkable problem, especially when the 
patients have to undergo repeated biopsies, because 
the pain can cause the patients to reject such a 
8procedure.
Pain during TRUS guided prostate biopsy 
procedure may come from two sources, from the 
TRUS probe insertion and biopsy needle puncture. 
TRUS probe insertion pain occurs due to the 
pressure of the probe innervation in the rectum 
below the dentate line by the inferior rectal branch of 
the pudendal nerve. Pain results from multiple 
puncture biopsy needle into the prostate capsule and 
stroma, innervated by the autonomic branch of NVB 
6,8,11between posterolateral prostate and rectum.
Puncture biopsy needle penetrates through 
the rectal wall at the lower sensory area above the 
dentate line, and penetrates the prostate capsule and 
stroma during biopsy needle penetration. This 
penetration causes periprostatic nerves stimulate 
5,7sensory receptors in the prostate capsule.  Prostatic 
capsule and stroma contains many autonomic nerve 
fibers (C-fibers), which carry visceral sensation 
from spinal cord. Parasympathetic innervation of 




Total No pain Mild pain Moderate pain
≤ 30 4 (44,4) 1 (11,1) 4 (44,4) 9 (100,0) 
31 – 40 0 (0,0) 5 (83,3) 1 (16,7) 6 (100,0) 
> 40 1 (8,3) 7 (58,3) 4 (33,3) 12 (100,0) 
Total 5 (18,5) 13 (48,1) 9 (33,3) 27 (100,0)
 
Table 3. Correlation between VAS and prostate volume.
innervation of the presacral plexus and hypogaster. 
The nerve fibers are branched in the prostatic plexus 
and passes through the vascular pedicle of the 
prostate at posterolateral base of the prostate at the 
end of the seminal vesicles between prostate and 
rectum. So painful because the needle biopsy can be 
addressed with local anesthetic infiltration into the 
3,10,11region of innervation.
In this study, patients' pain perception was 
measured by VAS. Degree of pain is difficult to 
measure because subjective interpretation of results. 
In the last three decades, VAS has been shown to 
provide satisfactory results in measuring subjective 
pain. Due to its sensitivity, VAS has been the best 
method of measuring the perception of pain or pain 
3treatment.  To eliminate the factor of inter-observer 
variability, the assessment of pain perception using 
VAS method of prostate biopsy should be performed 
8by the same operator in all patients.
Clinician experience shows that TRUS 
prostate biopsy cause discomfort and pain, of which 
24% of the patients feel moderate-severe pain with 
16VAS > 5.  Research in the Department of Cipto 
Mangunkusumo, as much as 77,5% of patients with 
prostate biopsy without anesthesia and analgesia 
experienced moderate and severe pain, with an 
17average VAS 5.
Previous data indicated that the PNB 
method is the best for reducing pain in TRUS 
prostate biopsy, and most urologists agree PNB is the 
gold standards for the control of pain in prostate 
8biopsy.  PNB can be accepted with the consideration 
that the area of anesthesia in accordance with the 
anatomical source of pain, where the source of the 
pain comes from the prostate capsule and stroma that 
contains many innervation of autonomic basolateral 
fibers along the vascular pedicle. Pain can be caused 
by direct contact between the needle with the nerve 
18to the capsule and prostatic stroma.
In this study, the administration of 
ketoprofen 200 mg suppository before prostate 
biopsy demonstrated VAS value of 4,5 ± 1,6 VAS. 
Whereas, the periprostatic injection of 1% lidocaine 
Indonesian Journal of Urology, Vol. 19, No. 2, July 2012: 83 - 89
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revealed VAS of 0,8 ± 0,8. Statistical tests by 
independent t-test showed significant differences in 
pain perception with p < 0,0001, where the 
periprostatic injection of 1% lidocaine produces pain 
lower than ketoprofen suppository.
In a study comparing 100 mg diclofenac 
suppository with a placebo, it was shown that 
diclofenac produces significantly lower pain with a 
mean of VAS of 2,8 vs 4,9 on placebo, with p < 
0,001.11 Other researchers have also reported 
significant differences in mean VAS diclofenac 
suppository of 3,22 ± 2,09 and 5,03 ± 2,68 of 
19placebo, p value = 0,004.
Alavi (2001), who compared VAS in 10 ml 
periprostatic injection of 1% lidocaine with topical 
anesthetia with 10 ml of 2% lidocaine jelly in each of 
75 patients, reported better pain control in the 
lidocaine periprostatic injection periprostatika VAS 
2,4 ± 0,23 and lidocaine jelly 3,7 ± 0,35 (p = 
30,00002).  In contrast Mallick (2004) did not obtain 
significant differences between the two, with the 
periprostatic injection of lidocaine had VAS 2,0 ± 3,9 
compared with 2,6 ± 3,7 with lidocaine jelly, p = 
200,15.  Nash (2005), who compared periprostatic 
injection of 1% lidocaine on one side of the prostate 
and 0,9% NaCl in its contralater in 64 patients, 
reported a significant difference in VAS 1,6 ± 0,9 in 
periprostatic lidocaine injection and 2,9 ± 1,2 on 
10placebo (p < 0,0001).
Alvarino (2005) compared periprostatic 
injection of 1% lidocaine with placebo, and reported 
significant difference in VAS 2,1 ± 1,3 5,7 ± 1,7 
21compared to placebo with p < 0,05.  Leibovici 
(2002) also reported significant difference on both 
7the mean VAS 1 : 51 vs 3,98 (p = 0,0001).  Other 
researchers found significant differences in mean 
VAS periprostatic injection of 1% lidocaine 3,0 vs 
94,3 on placebo, p < 0,001.  In 50 patients with a 
prostate biopsy receiving periprostatic injection of 
1% lidocaine, only one patient had significant pain. 
Ten patients who previously had undergone prostate 
biopsy without anesthesia, experience a dramatic 
15reduction in pain compared to the previous biopsy.  
Similarly, Giannarini (2009) reported a VAS at PNB 
1,27 ± 1,19 ± 4,33 compared with no anesthesia 2,26; 
6p < 0,001.  
Bingqian (2009) reported that the combined 
injection of lidocaine 1% of GNP and intraprostatic 
reduce pain significantly when prostate biopsy with 
VAS 2,89 ± 1,09 compared to 3,56 ± 1,09 PNB itself. 
But the GNP itself is still significantly better than the 
84,81 ± 1,77 without anesthesia (p < 0,0001).
Pain after biopsy is due to the release of 
mediators, such as cytokines, prostaglandins, and 
leukotrienes, that cause local pain, edema, and the 
10,11release of other immune competent cells.  
Ketoprofen is an NSAID of the propionic acid 
derivative that has effectiveness as a moderate 
analgesic and anti-inflammatory. Mechanism of 
action of ketoprofen inhibits the biosynthesis of 
prostaglandins, substances that sensitisizes pain 
22receptors to mechanical and chemical stimulation,  
by blocking the enzyme cyclooxygenase (COX) that 
interferes with the conversion of arachidonic acid 
into prostaglandins, resulting in activation barriers 
of peripheral nociceptor important in the 
23pathophysiology of pain.
Lidocaine is a strong local anesthetic. 
Mechanism of action of lidocaine is by changing 
neuronal signal conduction by blocking Na channels 
in cell membranes of neurons that are responsible for 
signal propagation. Thus the membrane of the post-
synaptic neurone is not depolarized and fails to 
deliver action potential. This causes the anesthetic 
effect not only preventing the transmission of pain 
signals to the brain, but also thwart the occurrence of 
24pain in the first place.
In this study, we also assessed the 
correlation between the perception of pain (VAS) 
and the patient's age, where the Pearson correlation 
test p = 0,779 showed no significant correlation 
between the perception of pain by the patient's age at 
prostate biopsy. Similarly, no significant correlation 
was found between the perception of pain by the 
patient's and prostate volume on prostate biopsy, in 
which the Pearson correlation test showed p = 0,389.
In males aged < 60 years, 80% felt 
moderate-severe pain, and > 80% of patients age > 
2570 years of mild pain.  Men age < 65 years were 
more likely to feel pain during prostate biopsy, 
probably due to anal sphincter that is not capable of 
relaxation adequately. This corresponds to a negative 
correlation between age with the sensation and tone 
of the sphincter. It requires maximum control of the 
anorectal components in patients with rectal prostate 
6,8biopsy.  Local anesthesia in older patients may not 
8be useful, because the anal pain threshold is higher.
On a smaller prostate volume (< 48 ml), 
there was a significant difference in VAS between 
the combination of 1% lidocaine injection PNB and 
intraprostatic (2,7 ± 1,12), PNB (3,9 ± 1,24), with no 
anesthesia (4,5 ± 1,76), p = 0,0001. Although there 
was no difference in prostate volume was higher (> 
48 ml), p = 0,185. Those with age < 66 years also 
Azis: The difference of pain perception 
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showed significant difference in VAS between PNB 
combination and intraprostatic (2,5 ± 0,96), PNB 
(4,1 ± 1,33), and with no anesthesia (4,4 ± 1,17), p < 
0,0001, although there was no difference in older 
8age, p = 0,155.
In contrast, Leibovici (2002) reported that 
age and prostate size did not affect the level of pain, 
in the study 90 patients with a prostate biopsy 1% 
7lidocaine periprostatic injection and placebo.  
Similarly, Mallick (2004) reported that age and 
prostate volume did not affect VAS values of the 
patients in the provision of lidocaine jelly and 1% 
20lidocaine periprostatic injection.
PNB technique is more advantageous than 
an perianal-intrarectal analgesic cream in the 
prostates with volume > 49 ml, because the cream in 
perianal-intrarectal only acts on the level of the anal 
sphincter and its spread into innervation fibers of the 
prostate capsule is adequate only in smaller prostate 
gland. In large prostates we require wider and longer 
TRUS probe manipulation to obtain good imaging 
6and guiding sampling.  Additionally, larger prostates 
8also requires more lidocaine in prostate biopsy.
CONCLUSION
There was significant differences in pain 
perception between the administration of ketoprofen 
suppositories with 1% lidocaine periprostatic 
injection in TRUS guided prostate biopsy, in which 
periprostatic injection of 1% lidocaine provided 
better pain control than ketoprofen suppository. No 
significant correlation exists between the perception 
of pain with patients' age and prostate volume on 
TRUS guided prostate biopsy.
5. Autorino R, Sio MD, Lorenzo GD, Damiano R, 
Perdona S, Cindolo L, et al. How to decrease pain 
during transrectal ultrasound guided prostate biopsy: 
A look at the literature. J Urol. 2005; 174: 2091–7.
6. Giannarini G, Autorino R, Valent F, Mogorovich A, 
Manassero F, Maria MD, et al. Combination of 
perianal-intrarectal lidocaine-prilocaine cream and 
periprostatic nerve block for pain control during 
transrectal ultrasound guided prostate biopsy: A 
randomized, controlled trial. J Urol. 2009; 181: 
585–93.
7. Leibovici D, Zisman A, Siegel YI, Sella A, 
Kleinmann J, Lindner A. Local anesthesia for prostate 
biopsy by periprostatic lidocaine injection: A double-
blind placebo controlled study. J Urol. 2002; 167: 
563–5.
8. Bingqian L, Peihuan L, Yudong W, Jinxing W, 
Zhiyong W. Intraprostatic local anesthesia with 
periprostatic nerve block for transrectal ultrasound 
guided prostate biopsy. J Urol. 2009; 182: 479–84.
9. Addla SK, Adeyoju AAB, Wemyss-holden GD, 
Neilson D. Local anaesthetic for transrectal 
ultrasound-guided prostate biopsy: A prospective, 
randomized, double blind, placebo-controlled study. 
Eur Urol. 2003; 43: 441–3. 
10. Nash PA, Bruce JE, Indudhara R, Shinohara K. 
Transrectal ultrasound guided prostatic nerve 
blockade eases systematic needle biopsy of the 
prostate. J Urol. 1996; 155: 607–9.
11. Haq A, Patel HRH, Habib MR, Donaldson PJ, Parry 
JRW. Diclofenac suppository analgesia for transrectal 
ultrasound guided biopsies of the prostate: A double-
blind, randomized controlled trial. J Urol. 2004; 171: 
1489–91.
12. Lee HY, Lee HJ, Byun SS, Lee SE, Hong SK, Kim 
SH. Effect of intraprostatic local anesthesia during 
transrectal ultrasound guided prostate biopsy: 
Comparison of 3 methods in a randomized, double-
blind, placebo controlled trial. J Urol. 2007; 178: 
469–72. 
13. Taverna G, Maffezzini M, Benetti A, Seveso M, 
Giusti G, Graziotti P. A single injection of lidocaine as 
local anesthesia for ultrasound guided needle biopsy 
of the prostate. J Urol. 2002; 167: 222–3.
14. Mutaguchi K, Shinohara K, Matsubara A, Yasumoto 
H, Mita K, Usui T. Local anesthesia during 10 core 
biopsy of the prostate: Comparison of 2 methods. J 
Urol. 2005; 173: 742–5.
15. Soloway MS, Obek C. Periprostatic local anesthesia 
before ultrasound guided prostate biopsy. J Urol. 
2000; 163: 172–3.
16. Crundwell MC, Cooke PW, Wallace DMA. Patients 
tolerance of transrectal ultrasound-guided prostatic 
biopsy; An audit of 104 cases. BJU Int. 1999; 83: 
792-5.
17. Tjahyo MD, Umbas R. Evaluasi toleransi pasien 
terhadap nyeri pada biopsi prostat transrektal dengan 
panduan ultrasonografi. Jurnal Urologi Indonesia. 
2003; 12: 17–9.
REFERENCES
1. Klein EA, Platz EA, Thompson IM. Epidemiology, 
etiology, and prevention of prostate cancer. 
Campbell-Walsh Urology. 9th ed. Philadelphia: WB 
Saunders. 2007; 90: 2845-57.
2. Heidenreich A, Bolla M. Guidelines on prostate 
cancer. European Association of Urology Guidelines; 
2010. p. 9–16.
3. Alavi AS, Soloway MS, Vaidya A, Lynne CM, 
Gheiler EL. Local anesthesia for ultrasound guided 
prostate biopsy: A prospective randomized trial 
comparing 2 methods. J Urol. 2001; 166: 1343–5.
4. R a m e y  J R ,  H a l p e r n  E J ,  G o m e l l a  L G .  
Ultrasonography and biopsy of the prostate. 
Campbell-Walsh Urology. 9th ed. Philadelphia: WB 
Saunders. 2007; 92: 2883–92.
Indonesian Journal of Urology, Vol. 19, No. 2, July 2012: 83 - 89
89
18. Cam K, Sener M, Kayikci A, Akman Y, Erol A. 
Combined periprostatic and intraprostatic local 
anesthesia for prostate biopsy: A double-blind, 
placebo controlled, randomized trial. J Urol. 2008; 
180: 141–5.
19. Afdal, Umbas R. Evaluasi nyeri biopsi prostat 
transrektal dengan pemberian Na Diklofenak 100 mg 
suppositoria. Sub Bagian Urologi FKUI; 2005. 
p. 1–10.
20. Mallick S, Humbert M, Braud F, Fofana M, Blanchet 
P. Local anesthesia before transrectal ultrasound 
guided prostate biopsy: Comparison of 2 methods in a 
prospective, randomized clinical trial. J Urol. 2004; 
171: 730–3.
21. Alvarino, Umbas R. Penggunaan anestesi lokal 
periprostat sebelum biopsi prostat transrektal. 
Majalah Kedokteran Indonesia. 2005; 55: 397-401.
22. Wilmana PF. Analgesik-antipiretik analgesik anti-
inflamasi nonsteroid dan obat pirai. Farmakologi dan 
terapi. 4th ed. Jakarta: Gaya Baru; 2003. p. 208–18.
23. White PF. The role of nonopioid analgesic techniques 
in the management of postoperative pain. Textbook of 
Regional Anesthesia and Acute Pain Management. 
New York: McGraw Hill; 2007. p. 1109-10.
24. Sunaryo. Kokain dan anestetik lokal sintetik. 
Farmakologi dan terapi. 4th ed. Jakarta: Gaya Baru; 
2003. p. 234–41.
25. Cevik I, Ozveri H, Ozdal D, Akdas A. Lack of effect of 
intrarectal lidocaine for pain control during 
transrectal prostate biopsy: A randomized prospective 
study. Eur Urol. 2002; 42: 217–20.
Azis: The difference of pain perception 
